Market cap
$229.2m
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Revenue grew 40.4% and PBT rose 107.9%, but HY24's discontinued operation and negative tax rate make the comparison unreliable.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$229.2m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not available for this company right now.
EPS
Not available
Not available for this company right now.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not available for this company right now.
P/B
0.32x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY25 vs HY24
Revenue
$916.8m
Caveat: metric quality flags apply; use this value with basis context.
EBITDA
$63.1m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$4.8m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
−$12m
Caveat: metric quality flags apply; use this value with basis context.
Operating profit
$34.1m
Caveat: metric quality flags apply; use this value with basis context.
Profit before tax
$7.5m
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
$49m
+60.8% ↑ vs $30.5m
Total assets
$1.7b
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofSML HY25Result releasedAnnolyse analysis published
What changed
Revenue rose 40.4% to $916.8m, a level Annolyse's historical baseline classifies as unprecedented against a five-period mean of just 1.0% growth, which itself signals the comparison is not like-for-like. EBITDA lifted to $63.1m, about 3.2x the prior comparable period's $19.9m, while PBT moved from a $94.9m loss to a $7.5m profit (+107.9%) and NPAT swung from a $96.2m loss to $4.8m (+105.0%). Gross borrowings fell 25.2% to $440.9m and equity rose 14.0% to $796.7m.
What matters
HY24 carried a $26.2m after-tax loss from a discontinued operation plus a deeply loss-making continuing business, so the 40.4% revenue and 107.9%/105.0% PBT/NPAT growth figures compare against a trough, not a normal period; this matters because investors reading these as organic momentum would overstate the run-rate improvement.
Tax line adds noise, not clarity. The effective tax rate was -35.9% versus -26.3% in the prior half, both unprecedented against a historical mean near 14.7%, meaning the 2.9 percentage-point PBT-to-NPAT growth gap reflects a tax credit rather than an operating swing; PBT is the cleaner read on the underlying turnaround.
Working-capital and cash signals are mixed. Inventory days fell to 68.9, below the historical range (mean 105.7 days), a favourable shift, while debtor days rose to 36.1, at the upper edge of the historical range (mean 33.7 days); inventories in dollar terms still grew 9.8% to $347.1m, which ties up cash even as days-on-hand improved.
Expectations
Historical seasonality context shows HY24 contributed only 39.9% of FY24 revenue and, unusually, more than half (52.8%) of FY24's full-year NPAT loss came in the first half, meaning half-on-half shape has been erratic in recent years and this HY25 result should not be extrapolated to a full-year outcome without a second-half read.
Quality of result
However, operating cash flow remained negative at $12.0m and pre-lease free cash flow was still negative at $23.4m, so the reported NPAT of $4.8m was not backed by positive operating or free cash generation this half. Cash conversion improved from the prior comparable but the ratio itself is denominator-distorted given the small and volatile EBITDA and cash-flow bases, so it should not be read as a normal analytical signal in either period. The inventory-day improvement is encouraging for working-capital efficiency, but the rise in debtor days and the $30.8m increase in inventories on the balance sheet suggest some of the cash improvement is timing-related rather than fully structural.
Unresolved
This briefing cannot assess whether the improved leverage and inventory metrics will hold through the second half, since no forward guidance or dividend policy detail was supplied.
Chat
Ask follow-up questions about Synlait Milk's HY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
NZX Results Template
HY25 / results announcementSynlait Half Year 2025 Announcement
HY25 / results releaseSynlait Half Year 2025 Financial Statements
HY25 / financial reportSynlait Half Year 2025 Investor Presentation
HY25 / results presentationNZX Results Template
HY24 / results announcementSynlait Half Year 2024 Announcement
HY24 / results releaseSynlait Half Year 2024 Financial Statements
HY24 / financial reportNZX Results Template
FY24 / results announcementSynlait Full Year 2024 Annual Report
FY24 / financial reportSynlait Full Year 2024 Media Release
FY24 / media releaseAnnouncement: Return to profitability with HY25 guidance provided
HY25 / commentaryAnnouncement: Synlait Annual Meeting 2024 Poll Results
HY25 / commentaryAnnouncement: Synlait HY25 results date and conference call details
HY25 / commentaryAnnual Meeting Director Nominations
HY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 2.9pp, with a distortion flag in the result.
Leverage and balance-sheet risk
Net debt / EBITDA is 6.20x for this result.
Revenue growth context
Revenue growth was 40.4% for this reporting period.
ROE and capital efficiency
ROE was 0.6%, +15.4pp versus the prior comparable period.
Get the next Synlait Milk briefing and related NZX reporting-season updates by email.